Crescent City Clinical Research Center, LLC

Metairie, Louisiana 70006

0 studies enrolling now · 7 studies all time

What they study most

Chronic Kidney Disease, Diabetes Mellitus, Type 1, Diabetic Retinopathy, Hyperlipidemia, Hypoparathyroidism, Type 2 Diabetes Mellitus

Studies at this site

• An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants — Completed
• Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism — Stopped early
• A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR) — Completed
• Mylan Insulin Aspart Study — Completed
• Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin — Completed